Neurontin (Gabapentin)

Gabapentin binds to the α2δ subunit of voltage‑gated calcium channels in the central nervous system. This binding reduces calcium influx into neurons, which in turn lowers the release of excitatory neurotransmitters such as glutamate and substance P, dampening neuronal hyper‑excitability associated with seizures and pain.

The appropriate dose of Neurontin is individualized by the prescribing clinician based on the specific indication, patient age, renal function and response to therapy. Dosage regimens can vary widely, so the prescriber determines the exact amount and schedule.

Safety data for gabapentin in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy or breastfeeding should discuss risks with their healthcare provider.

To place an order, submit an enquiry on the Neurontin product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other neuropathic pain medications such as pregabalin or tricyclic antidepressants, gabapentin has a distinct mechanism targeting calcium channels. It is generally well tolerated but may cause more sedation than some alternatives. Choice of therapy depends on efficacy, side‑effect profile, patient comorbidities and cost considerations.

Neurontin should be stored at ambient temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture, direct sunlight and excessive heat to maintain potency throughout the shelf life.

Neurontin is taken orally, usually as a tablet. The dose is divided throughout the day and can be taken with or without food. Patients should follow the prescribing clinician’s instructions regarding timing and whether to swallow the tablet whole or with a small amount of water.

Serious risks include severe allergic reactions such as Stevens‑Johnson syndrome, anaphylaxis, suicidal thoughts or behaviors, respiratory depression when combined with other depressants, and rare blood disorders. Patients should seek immediate medical attention if they notice rash, swelling, mood changes or breathing difficulties.

Neurontin is contraindicated in individuals with known hypersensitivity to gabapentin or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled depression, or a history of suicidal ideation. Pregnant or breastfeeding women should only use it under strict medical supervision.